{
    "2021-08-10": [
        [
            {
                "time": "2021-08-10",
                "original_text": "贝莱德减持泰格医药(03347)12.2万股，每股作价约152.74港元 减持股份",
                "features": {
                    "keywords": [
                        "贝莱德",
                        "减持",
                        "泰格医药",
                        "12.2万股",
                        "152.74港元"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-10",
                "original_text": "泰格医药(03347.HK)委任吴灏为公司联席总裁",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "吴灏",
                        "联席总裁"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-10",
                "original_text": "【权益变动】泰格医药(03347.HK)被贝莱德减持12.2万股 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "贝莱德",
                        "减持",
                        "12.2万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-10",
                "original_text": "港股医药外包概念股走弱，维亚生物跌7.4%，方达控股跌5.14%，昭衍新药跌4.3%，泰格医药跌1.8%",
                "features": {
                    "keywords": [
                        "港股",
                        "医药外包",
                        "维亚生物",
                        "方达控股",
                        "昭衍新药",
                        "泰格医药"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-10",
                "original_text": "神经介入植入医疗器械研发商励楷科技完成数亿元B轮融资，恒旭资本领投",
                "features": {
                    "keywords": [
                        "励楷科技",
                        "融资",
                        "恒旭资本",
                        "B轮"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}